1-6 of 6
Alain Thibault
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tipifarnib (Zarnestra, R115777) as Maintenance Therapy for Adults in Complete Remission (CR) Following Induction and Consolidation Therapies for Poor-Risk Acute Myelogenous Leukemia (AML): A Phase II Trial.

Judith E. Karp, MD, Ivana Gojo, MD, Jacqueline Greer, R.N., B. Douglas Smith, MD, Maureen Klein, R.N., Jeffery E. Lancet, MD, Steven D. Gore, MD, Lawrence Morris, MD, Alain Thibault, MD, Mary Ellen Rybak, MD, John J. Wright, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2783.
https://doi.org/10.1182/blood.V106.11.2783.2783
Published: 2005
Journal Articles

Gene Expression Profiling Predictive of Tipifarnib (ZARNESTRA ® , R115777) Response in Patients with Newly Diagnosed Acute Myeloid Leukemia.

Mitch Raponi, MD, Yi Zhang, PhD, Tim Jatkoe, MD, Jack Yu, PhD, Grace Lee, MD, Jeffrey E. Lancet, MD, Judith E. Karp, MD, Alain Thibault, MD, Yixin Wang
Journal: Blood
Blood (2005) 106 (11): 2785.
https://doi.org/10.1182/blood.V106.11.2785.2785
Published: 2005
Journal Articles

Identification of Molecular Predictors of Response to ZARNESTRA™ (Tipifarnib, R115777) in Relapsed and Refractory Acute Myeloid Leukemia.

Mitch Raponi, Bob Lowenberg, Jeffrey E. Lancet, Jean-Luc Harousseau, Richard Stone, Wayne Rackoff, Alain Thibault, Yi Zhang, David Atkins, Yixin Wang
Journal: Blood
Blood (2004) 104 (11): 861.
https://doi.org/10.1182/blood.V104.11.861.861
Published: 2004
Journal Articles

Tipifarnib (ZARNESTRA TM in Previously Untreated Poor-Risk AML of the Elderly: Updated Results of a Multicenter Phase 2 Trial.

Jeffrey E. Lancet, MD, Jason Gotlib, MD, Ivana Gojo, MD, Eric J. Feldman, MD, Lawrence Morris, MD, Alain Thibault, MD, Jane L. Liesveld, MD, Jacqueline Greer, RN, Kathleen Dugan, RN, Mitch Raponi, PhD, John J. Wright, MD, PhD, Peter L. Greenberg, MD, Judith E. Karp, MD
Journal: Blood
Blood (2004) 104 (11): 874.
https://doi.org/10.1182/blood.V104.11.874.874
Published: 2004
Journal Articles

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

Clinical Trials & Observations
Jorge Cortes, Maher Albitar, Deborah Thomas, Francis Giles, Razelle Kurzrock, Alain Thibault, Wayne Rackoff, Charles Koller, Susan O'Brien, Guillermo Garcia-Manero, Moshe Talpaz, Hagop Kantarjian
Journal: Blood
Blood (2003) 101 (5): 1692–1697.
https://doi.org/10.1182/blood-2002-07-1973
Published: 2003
Journal Articles

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Clinical Trials & Observations
Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, John J. Wright, Kees Bol, Ivan Horak, Michael L. Tidwell, Jane Liesveld, Timothy J. Kottke, Dawn Ange, Laxmi Buddharaju, Ivana Gojo, W. Edward Highsmith, Robert T. Belly, Raymond J. Hohl, Mary Ellen Rybak, Alain Thibault, Joseph Rosenblatt
Journal: Blood
Blood (2001) 97 (11): 3361–3369.
https://doi.org/10.1182/blood.V97.11.3361
Published: 2001